510(k) Report

510(k) · Cleared

Recalled · 2010

Depuy Asr 300 Acetabular Cup System

K073413510(k) SpecialCleared Jan 30, 200857-day reviewClass III21 CFR 888.3330Recalls 36

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DePuy Orthopaedics, Inc. · KWA Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component)

Cleared on Jan 30, 2008 as substantially equivalent to K040627 (DePuy Orthopaedics, Inc., 2005) and 1 other predicate after a 57-day review. Its family tree reaches back 3 generations to 1993. 1 later device descends from it. It has been recalled 36 times.

Decided
Jan 30, 2008
Review
57 days
Class
Class III
Product code
KWA
Recalls
36
Predicates
3

Its longest line of descent runs back 3 generations to K930712 (1993). 13 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor2002: 1 other ancestor2000: 2 other ancestors1997: 1 other ancestor2001: 1 other ancestor1996: 1 other ancestor1995: 2 other ancestors1994: 1 other ancestor2008: 1 descendant clearedK930712 · P.F.C. Total Hip System Porous Coated Modular · Johnson & Johnson Orthopaedics, Inc. · 1993K983014 · Summit Acetabular System · Johnson & Johnson Professionals, Inc. · 1998K000306 · Pinnacle Acetabular System · DePuy Orthopaedics, Inc. · 2000 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 4 other ancestors3 generations back: 5 other ancestors 1 generation forward: 1 descendant K000306 · Pinnacle Acetabular System · DePuy Orthopaedics, Inc. · 2000 · recalledK983014 · Summit Acetabular System · Johnson & Johnson Professionals, Inc. · 1998K930712 · P.F.C. Total Hip System Porous Coated Modular · Johnson & Johnson Orthopaedics, Inc. · 19930
  1. Root · 3 generations backK930712 P.F.C. Total Hip System Porous Coated ModularJohnson & Johnson Orthopaedics, Inc. · 1993
  2. 2 generations backK983014 Summit Acetabular SystemJohnson & Johnson Professionals, Inc. · 1998
  3. 1 generation backK000306 Pinnacle Acetabular SystemDePuy Orthopaedics, Inc. · 2000 · Recalled
  4. This deviceK073413 Depuy Asr 300 Acetabular Cup SystemDePuy Orthopaedics, Inc. · 2008
  5. Descendant · cites it directly · 0 of its ownK080991 Depuy Asr XL Modular Acetabular Cup SystemDePuy Orthopaedics, Inc. · 2008 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K080991Depuy Asr XL Modular Acetabular Cup SystemDePuy Orthopaedics, Inc. · 2008 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K930712P.F.C. Total Hip System Porous Coated ModularJohnson & Johnson Orthopaedics, Inc.1993—
−2K983014Summit Acetabular SystemJohnson & Johnson Professionals, Inc.1998—
−1K000306Pinnacle Acetabular SystemDePuy Orthopaedics, Inc.20001
0 (this device)K073413Depuy Asr 300 Acetabular Cup SystemDePuy Orthopaedics, Inc.2008—
+1K080991Depuy Asr XL Modular Acetabular Cup SystemDePuy Orthopaedics, Inc.200841

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199520
199610
199710
200020
200110
200210
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
FIG. 1 — Lineage of K073413, 1993–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KWA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
*K040627Depuy Asr Modular Acetabular Cup System
Summary page 1
…sis DEVICE PRODUCT CODE: 87 KWA SUBSTANTIALLY EQUIVALENT DePuy ASRTM Modular Acetabular Cup System, DEVICE: K040627 DePuy Pinnacle® Acetabular Cup System, K000306…
DePuy Orthopaedics, Inc.200555
*K000306Pinnacle Acetabular System
Summary page 1
…System, DEVICE: K040627 DePuy Pinnacle® Acetabular Cup System, K000306 Porocoat Lunceford Acetabulum, K823145 $,0…
DePuy Orthopaedics, Inc.20001
Kept off the family treeK823145Porocoat Lunceford Acetabulum
Not in FDA’s 510(k), De Novo or PMA lists as we hold them (a misreading, a typo, or a number FDA does not list), so it is kept off the family tree
Summary page 1
…DePuy Pinnacle® Acetabular Cup System, K000306 Porocoat Lunceford Acetabulum, K823145 $,0739i-3 (2. DEVICE DESCRIPTION: The subject DePuy ASRTM 300 Acetabular Cup S…

Also cleared against K040627: 4 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K080991Depuy Asr XL Modular Acetabular Cup SystemDePuy Orthopaedics, Inc.20080

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 23, 2010Not classifiedZ-1803-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1799-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1798-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1796-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1802-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1801-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1795-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1804-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1800-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1797-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Mar 5, 2010Not classifiedZ-2048-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2055-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2038-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2049-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2056-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2053-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2057-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2058-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2050-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2037-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2044-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2042-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2054-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-203-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2046-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2059-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2051-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2035-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2047-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2043-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2040-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2039-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2045-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2041-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2052-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2036-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 3 companies; a new generation was cleared every 5.1 years on median.
  • 2 of the 13 ancestors have a recall of any class.
  • Of its descendants, K080991 (DePuy Orthopaedics, Inc., 2008) has gone furthest, with 0 descendants of its own.
  • 4 other devices also cite its predicate K040627.

How does its category compare?

All KWA devices

KWA Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component): FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · KWA

4in 2012

2007: 82008: 92009: 72010: 62011: 112012: 4
2007high 11 (2011) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KWA

76in 2012

2007: 74 days median2008: 57 days median2009: 139 days median2010: 167 days median2011: 101 days median2012: 76 days median
2007high 167 (2010) · low 57 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KWA

19in 2023

2008: 132010: 842011: 282012: 212013: 12016: 12017: 12018: 12019: 22020: 12023: 19
2007high 84 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KWA

1,216in 2025

2007: 2132008: 7622009: 8202010: 3,3482011: 17,7372012: 24,6012013: 20,0202014: 16,4942015: 12,3392016: 7,8722017: 6,8472018: 6,3882019: 7,6282020: 4,5382021: 2,0642022: 1,6172023: 1,4742024: 1,1682025: 1,216
2007high 24,601 (2012) · low 213 (2007)2025

MAUDE reports naming product code KWA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078740213
200895713762
200971390820
20106167843,348
2011111012817,737
20124762124,601
20130—120,020
20140—016,494
20150—012,339
20160—17,872
20170—16,847
20180—16,388
20190—27,628
20200—14,538
20210—02,064
20220—01,617
20230—191,474
20240—01,168
20250—01,216
20260—0—

What is it indicated for?

The device is indicated for use in total hip replacement procedures for patients suffering severe pain and disability due to structural damage in the hip joint from rheumatoid arthritis, osteoarthritis, post-traumatic arthritis, collagen disorders, avascular necrosis, and nonunion of femoral fractures. Use of the prosthesis is also indicated for patients with congenital hip dysplasia, slipped capital femoral epiphysis and disability due to previous fusion, where bone stock is inadequate for other reconstruction techniques.

Porous-coated ASR 300 Acetabular Cups are indicated for cementless application.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K073413: Depuy Asr 300 Acetabular Cup System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K073413

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026